Search

Your search keyword '"Dewit, O."' showing total 338 results

Search Constraints

Start Over You searched for: Author "Dewit, O." Remove constraint Author: "Dewit, O."
338 results on '"Dewit, O."'

Search Results

1. Preference for a prefilled syringe or an auto-injection device for delivering golimumab in patients with moderate-to-severe ulcerative colitis: a randomized crossover study

2. Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection

5. DOP40 Corticosteroid discontinuation and clinical outcomes in patients with moderately to severely active Crohn’s disease treated with upadacitinib

7. Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab

8. Profile of pediatric Crohn's disease in Belgium

13. How to manage inflammatory bowel disease patients when they withdraw anti-TNF due to severe anti-TNF-induced skin lesions? A multicenter cohort study

14. A phase 1b/2a multicenter study of the safety and preliminary pharmacodynamic effects of selective muscarinic M1 receptor agonist HTL0018318 in patients with mild-to-moderate Alzheimer's disease.

15. Effectiveness and persistence of Vedolizumab in patients with inflammatory bowel disease : results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE).

17. How to Manage Inflammatory Bowel Disease Patients When They Withdraw Anti-Tumour Necrosis Factor [Anti-TNF] Due to Severe Anti-TNF-Induced Skin Lesions? A Multicentre Cohort Study

18. Should we introduce early a new biological agent in patients with Inflammatory Bowel Disease after anti-TNF discontinuation due to severe anti-TNF-induced skin lesions? A multicenter cohort study

20. Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data

21. P472 Changes in colectomy for Ulcerative Colitis during the last two decades: an in-depth retrospective analysis

22. OP28 A randomized placebo controlled clinical trial with 5-hydroxytryptophan in patients with quiescent Inflammatory Bowel Disease and fatigue (Trp-IBD)

23. P558 Should we introduce early a new biological agent in patients with Inflammatory Bowel Disease after anti-TNF discontinuation due to severe anti-TNF-induced skin lesions? A multicenter cohort study

28. Effectiveness and persistence of Vedolizumab in patients with inflammatory bowel disease : results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE)

39. IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes

42. P422 Tofacitinib induces clinical and endoscopic remission in biologic refractory ulcerative colitis patients: a real-world Belgian cohort study

43. OP27 Long-term safety and efficacy of risankizumab treatment in patients with Crohn’s disease: Final results from the Phase 2 open-label extension study

44. IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes

45. Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

48. IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes

49. Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab.

50. Methotrexate for Corticosteroid- Dependent Ulcerative Colitis: Results of a Placebo Randomized Controlled Trial

Catalog

Books, media, physical & digital resources